Biodefense is Estimated to Witness High Growth Owing to Growing Threat of Biological Weapons
Biodefense Market |
The global Biodefense Market is
estimated to be valued at US$ 13.4 Bn in
2023 and is expected to exhibit a
CAGR of 4.8% over the forecast period 2023 to 2030, as highlighted in a new
report published by Coherent Market Insights.
Biodefense products such as
vaccines, antibiotics, and antimicrobial drugs help to protect humans from any
biological weapons and infectious diseases. With growing threats of biological
warfare and the emergence of new infectious diseases, the demand for biodefense
products is increasing significantly. The growing prevalence of infectious
diseases and rising awareness about pandemic preparedness are some major
factors driving the growth of the biodefense market.
Market Overview:
The global biodefense market
offers variety of medical countermeasures such as vaccines, drugs, and
diagnostics to protect against biological threats. Advancements in artificial
intelligence and big data analytics are helping researchers develop new
generation biodefense products with enhanced efficacy and safety.
Market key trends:
One of the key trends in the
biodefense market is the growing adoption of artificial intelligence. AI is
being used for pathogen detection, drug discovery, vaccine design, and
epidemiological modeling. AI-based tools can analyze huge datasets on pathogens
and epidemiology to predict future outbreaks. Pharmaceutical companies are also
developing AI-powered platforms for rapid vaccine design against emerging and
genetically evolving pathogens. This is significantly reducing the time
required for vaccine development.
Segment Analysis
The global biodefense market is
segmented into product type, application, and end user. Based on product type,
the biodefense market is segmented into anthrax, smallpox, botulism,
radiation/nuclear defense, and others. The anthrax segment dominated the market
in 2023 due to rising threats and preventive measures being taken by
governments across the globe. The application segments include drugs and
vaccines. The drugs segment is expected to be the largest shareholder due to
increasing R&D investments in antiviral drugs over the forecast period.
Based on end user, the market is segmented into hospitals, clinics, pharmacies,
and others. Hospitals accounted for the largest share of the biodefense market
in 2023.
Key Takeaways
The Global
Biodefense Market Size is expected to witness high growth, exhibiting
CAGR of 4.8% over the forecast period, due to increasing threats of biological
warfare and terrorism globally. North America dominated the global market in
2023 due to huge investments by governments in the biosecurity sector in the
region. The Asia Pacific region is expected to be the fastest-growing market
over the forecast period, growing at a CAGR of around 6%, owing to the rising
government focus on preventing bioterrorism in developing nations.
Key players operating in the biodefense market are Emergent
Biosolutions Inc., SIGA Technologies Inc., Bavarian Nordic A/S, Elusys
Therapeutics Inc., Ichor Medical Systems Inc., Amgen Inc., Cleveland BioLabs
Inc., Dynavax Technologies Corporation, Alnylam Pharmaceuticals Inc., and XOMA
Corporation. Emergent Biosolutions Inc. accounted for the largest revenue share
of over 20% in 2023 owing to its strong product portfolio in the anthrax
vaccine and antitoxin segment. SIGA Technologies Inc. held the second largest
market share and has a robust product pipeline for smallpox therapeutics.
The global biodefense market size
was valued at US$ 13.4 Bn in 2023. Biodefense comprises drugs, vaccines, and
diagnostic tools aimed at countering biological threats such as anthrax,
smallpox, plague, botulism, and others. Rising government investments,
increasing R&D activities, and growing product approvals are expected to
further drive market growth over the forecast period. The development of new
and improved therapeutics, diagnostics, and prophylactic vaccines will also
contribute to revenue generation in the coming years. However, high development
costs and regulatory challenges associated with biodefense products may hamper
market growth to some extent.
Read more
https://www.dailyprbulletin.com/biodefense-market-size-share-growth-outlook-2023/
Comments
Post a Comment